Maria M. Posada
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 12
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 12
- Pharmaceutical Science top 10%
- Drug Solubulity and Delivery Systems 2
-
- Renal Transplantation Outcomes and Treatments 2
-
- Pharmacological Effects and Toxicity Studies 6
-
- Analytical Chemistry and Chromatography 3
-
- Advanced Breast Cancer Therapies 2
-
- Chronic Lymphocytic Leukemia Research 2
- Co-authors
- Stephen D. HallDavid E. SmithKathleen M. HillgrenAleksandra GaletinChristopher R. JonesDaniel ScotcherAmin Rostami‐HodjeganY. Anne Pak
- Journals
- Cancer Research (1 paper)The FASEB Journal (1 paper)International Journal of Pharmaceutics (1 paper)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Maria M. Posada
21 papers receiving 505 citations
Peers
Comparison fields: 5 of 74
- Pharmacology 159
- Oncology 268
- Pharmaceutical Science 39
- Transplantation 17
- Pediatrics, Perinatology and Child Health 117
Countries citing papers authored by Maria M. Posada
This map shows the geographic impact of Maria M. Posada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria M. Posada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria M. Posada more than expected).
Fields of papers citing papers by Maria M. Posada
This network shows the impact of papers produced by Maria M. Posada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria M. Posada. The network helps show where Maria M. Posada may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Maria M. Posada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 5 | |
| 5 | 2020 | 39 | |
| 6 | 2019 | 1 | |
| 7 | 2019 | 25 | |
| 8 | 2018 | 25 | |
| 9 | 2018 | 7 | |
| 10 | 2017 | 5 | |
| 11 | 2017 | 55 | |
| 12 | 2017 | 1 | |
| 13 | 2016 | 28 | |
| 14 | 2016 | 37 | |
| 15 | 2016 | 3 | |
| 16 | 2014 | 54 | |
| 17 | 2012 | 28 | |
| 18 | 2007 | 4 | |
| 19 | 2007 | 19 | |
| 20 | 2006 | 31 |
About Maria M. Posada
Maria M. Posada is a scholar working on Pharmacology, Transplantation and Oncology, having authored 24 papers that have together received 509 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (12 papers), Pharmacogenetics and Drug Metabolism (12 papers), Pharmacological Effects and Toxicity Studies (6 papers), Analytical Chemistry and Chromatography (3 papers), Advanced Breast Cancer Therapies (2 papers), Renal Transplantation Outcomes and Treatments (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Drug Solubulity and Delivery Systems (2 papers). The work is most often cited by research in Pharmacology (159 citations), Oncology (268 citations) and Pharmaceutical Science (39 citations). Maria M. Posada has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Stephen D. Hall, David E. Smith, Kathleen M. Hillgren, Aleksandra Galetin, Christopher R. Jones, Daniel Scotcher, Amin Rostami‐Hodjegan, Y. Anne Pak, Gus R. Rosania and James A. Bacon. Their work appears in journals such as Cancer Research, The FASEB Journal and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.